Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways
Abstract The Fanconi anemia pathway in coordination with homologous recombination is essential to repair interstrand crosslinks (ICLs) caused by cisplatin. TIP60 belongs to the MYST family of acetyltransferases and is involved in DNA repair and regulation of gene transcription. Although the physical...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c4f9f089fbaf4a23a3f257a7acb65763 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c4f9f089fbaf4a23a3f257a7acb65763 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c4f9f089fbaf4a23a3f257a7acb657632021-12-02T15:05:56ZChronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways10.1038/s41598-017-04223-52045-2322https://doaj.org/article/c4f9f089fbaf4a23a3f257a7acb657632017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04223-5https://doaj.org/toc/2045-2322Abstract The Fanconi anemia pathway in coordination with homologous recombination is essential to repair interstrand crosslinks (ICLs) caused by cisplatin. TIP60 belongs to the MYST family of acetyltransferases and is involved in DNA repair and regulation of gene transcription. Although the physical interaction between the TIP60 and FANCD2 proteins has been identified that is critical for ICL repair, it is still elusive whether TIP60 regulates the expression of FA and HR genes. In this study, we found that the chemoresistant nasopharyngeal carcinoma cells, derived from chronic treatment of cisplatin, show elevated expression of TIP60. Furthermore, TIP60 binds to the promoters of FANCD2 and BRCA1 by using the chromatin immunoprecipitation experiments and promote the expression of FANCD2 and BRCA1. Importantly, the depletion of TIP60 significantly reduces sister chromatid exchange, a measurement of HR efficiency. The similar results were also shown in the FNACD2-, and BRCA1-deficient cells. Additionally, these TIP60-deficient cells encounter more frequent stalled forks, as well as more DNA double-strand breaks resulting from the collapse of stalled forks. Taken together, our results suggest that TIP60 promotes the expression of FA and HR genes that are important for ICL repair and the chemoresistant phenotype under chronic treatment with cisplatin.Wen-Pin SuYen-Chih HoCheng-Kuei WuSen-Huei HsuJia-Lin ShiuJheng-Cheng HuangSong-Bin ChangWen-Tai ChiuJan-Jong HungTsung-Lin LiuWei-Sheng WuPei-Yu WuWu-Chou SuJang-Yang ChangHungjiun LiawNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-15 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Wen-Pin Su Yen-Chih Ho Cheng-Kuei Wu Sen-Huei Hsu Jia-Lin Shiu Jheng-Cheng Huang Song-Bin Chang Wen-Tai Chiu Jan-Jong Hung Tsung-Lin Liu Wei-Sheng Wu Pei-Yu Wu Wu-Chou Su Jang-Yang Chang Hungjiun Liaw Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways |
description |
Abstract The Fanconi anemia pathway in coordination with homologous recombination is essential to repair interstrand crosslinks (ICLs) caused by cisplatin. TIP60 belongs to the MYST family of acetyltransferases and is involved in DNA repair and regulation of gene transcription. Although the physical interaction between the TIP60 and FANCD2 proteins has been identified that is critical for ICL repair, it is still elusive whether TIP60 regulates the expression of FA and HR genes. In this study, we found that the chemoresistant nasopharyngeal carcinoma cells, derived from chronic treatment of cisplatin, show elevated expression of TIP60. Furthermore, TIP60 binds to the promoters of FANCD2 and BRCA1 by using the chromatin immunoprecipitation experiments and promote the expression of FANCD2 and BRCA1. Importantly, the depletion of TIP60 significantly reduces sister chromatid exchange, a measurement of HR efficiency. The similar results were also shown in the FNACD2-, and BRCA1-deficient cells. Additionally, these TIP60-deficient cells encounter more frequent stalled forks, as well as more DNA double-strand breaks resulting from the collapse of stalled forks. Taken together, our results suggest that TIP60 promotes the expression of FA and HR genes that are important for ICL repair and the chemoresistant phenotype under chronic treatment with cisplatin. |
format |
article |
author |
Wen-Pin Su Yen-Chih Ho Cheng-Kuei Wu Sen-Huei Hsu Jia-Lin Shiu Jheng-Cheng Huang Song-Bin Chang Wen-Tai Chiu Jan-Jong Hung Tsung-Lin Liu Wei-Sheng Wu Pei-Yu Wu Wu-Chou Su Jang-Yang Chang Hungjiun Liaw |
author_facet |
Wen-Pin Su Yen-Chih Ho Cheng-Kuei Wu Sen-Huei Hsu Jia-Lin Shiu Jheng-Cheng Huang Song-Bin Chang Wen-Tai Chiu Jan-Jong Hung Tsung-Lin Liu Wei-Sheng Wu Pei-Yu Wu Wu-Chou Su Jang-Yang Chang Hungjiun Liaw |
author_sort |
Wen-Pin Su |
title |
Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways |
title_short |
Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways |
title_full |
Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways |
title_fullStr |
Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways |
title_full_unstemmed |
Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways |
title_sort |
chronic treatment with cisplatin induces chemoresistance through the tip60-mediated fanconi anemia and homologous recombination repair pathways |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/c4f9f089fbaf4a23a3f257a7acb65763 |
work_keys_str_mv |
AT wenpinsu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways AT yenchihho chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways AT chengkueiwu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways AT senhueihsu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways AT jialinshiu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways AT jhengchenghuang chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways AT songbinchang chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways AT wentaichiu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways AT janjonghung chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways AT tsunglinliu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways AT weishengwu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways AT peiyuwu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways AT wuchousu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways AT jangyangchang chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways AT hungjiunliaw chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways |
_version_ |
1718388670193467392 |